Page last updated: 2024-09-04

pyropheophorbide a and paclitaxel

pyropheophorbide a has been researched along with paclitaxel in 3 studies

Compound Research Comparison

Studies
(pyropheophorbide a)
Trials
(pyropheophorbide a)
Recent Studies (post-2010)
(pyropheophorbide a)
Studies
(paclitaxel)
Trials
(paclitaxel)
Recent Studies (post-2010) (paclitaxel)
10306331,8745,72915,395

Protein Interaction Comparison

ProteinTaxonomypyropheophorbide a (IC50)paclitaxel (IC50)
Integrin beta-3Homo sapiens (human)0.034
Integrin alpha-V Homo sapiens (human)0.034
ATP-dependent translocase ABCB1Homo sapiens (human)2.598
Botulinum neurotoxin type A Clostridium botulinum5.2
UDP-glucuronosyltransferase 2B7Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1-6Homo sapiens (human)4.9
Substance-K receptorHomo sapiens (human)6.125
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1A4Homo sapiens (human)4.9
UDP-glucuronosyltransferase 2B10 Homo sapiens (human)4.9
Delta-type opioid receptorHomo sapiens (human)4.202
Tyrosine-protein kinase MerHomo sapiens (human)4.9
Tubulin beta-3 chainHomo sapiens (human)0.0082
Beta-tubulin Leishmania donovani1
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)7.9433
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.26
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.28

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Q; Chen, Y; He, Z; Kan, Q; Li, Z; Luo, C; Sun, B; Sun, J; Sun, M; Wang, C; Wang, Y; Yu, H; Zhang, H; Zhang, X; Zhao, H1
Chen, Q; Chen, Y; He, Z; Luo, C; Sun, B; Sun, J; Wang, C; Yu, H; Zhang, X; Zhao, H1
Bu, J; Chang, E; Charron, DM; Chen, J; Coolens, C; Cui, D; Ding, L; Hou, W; Jeon, HH; Lou, JWH; Valic, M; Zheng, G1

Other Studies

3 other study(ies) available for pyropheophorbide a and paclitaxel

ArticleYear
Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 05-28, Volume: 302

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chlorophyll; Combined Modality Therapy; Dimerization; Drug Delivery Systems; Drug Liberation; Female; Fluorescent Dyes; Humans; Mice, Inbred BALB C; Nanocapsules; Neoplasms, Experimental; Optical Imaging; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Rats, Sprague-Dawley; Reactive Oxygen Species

2019
Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Acta biomaterialia, 2019, 07-01, Volume: 92

    Topics: Animals; Cell Death; Cell Line, Tumor; Chlorophyll; Drug Liberation; Endocytosis; Humans; Light; Mice, Nude; Nanoparticles; Oleic Acid; Paclitaxel; Photochemotherapy; Polyethylene Glycols; Prodrugs; Reactive Oxygen Species; Tissue Distribution; Xenograft Model Antitumor Assays

2019
A Nanoemulsion with A Porphyrin Shell for Cancer Theranostics.
    Angewandte Chemie (International ed. in English), 2019, 10-14, Volume: 58, Issue:42

    Topics: Animals; Chlorophyll; Drug Carriers; Emulsions; Ethiodized Oil; Humans; KB Cells; Mice, Nude; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Photoacoustic Techniques; Porphyrins; Theranostic Nanomedicine; Xenograft Model Antitumor Assays

2019